ACE2 and breast cancer: Angiotensin (1–7) fragment, the product of angiotensin-converting enzyme 2, and the non-peptide MAS-R agonist AVE0991 (mimics the effects of angiotensin (1–7)) decreased the migration/invasion of BC cells [28].